Phase II Trial to Evaluate Safety and Efficacy of GM-CSF/Sargramostim in Alzheimer's Disease
Abroad (travel likely)RecruitingPHASE2
Conditions
Alzheimer Disease
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States
Contact: Study coordinator (Neurology Research Partners) · neurologyresearchpartners@cuanschutz.edu · 3037244644
Study leads
Huntington Potter, PhD
Principal Investigator
University of Colorado Alzheimer's and Cognition Center